2021. Outcome of ivermectin treated mild to moderate COVID-19 cases: a single-centre, open-label, randomised controlled study. IMC Journal of Medical Science. 14, 2 (Apr. 2021), 11–18. DOI:https://doi.org/10.3329/imcjms.v14i2.52826.